Non-Canonical Tryptophan Synthesis Enabled by Larock Umpolung DOI Creative Commons

Jonathan Z. Huang,

Vanessa Y. Ying,

Mohammad R. Seyedsayamdost

и другие.

Опубликована: Июль 26, 2024

Tryptophan plays a critical role in diverse natural products, biological processes, and pharmaceutical molecules. Facile access to this amino acid its analogues from readily available building blocks, however, remains long-standing challenge. Here, we report regioselective synthesis of tryptophan unnatural variants bearing C4-C7 substituents via Rh-catalyzed annulation between structurally tert-butyloxycarbonyl (Boc) protected anilines serine derived alkynyl chloride. This transformation features C-H activation directed by weakly coordinating Boc group, the umpolung reactivity chloride, acetic acid-mediated reverse rhodation afford C2 unsubstituted indole products redox-neutral fashion. The wide utility chemistry is demonstrated for halogenated, borylated, poly-oxygenated tryptophans, drug analogues, dipeptides with crosslinks on tryptophan, heterocycle-containing derivatives. reaction will facilitate preparation compounds, notably myriad bioactive Trp-containing products.

Язык: Английский

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics? DOI Creative Commons
Kenji Hashimoto

European Archives of Psychiatry and Clinical Neuroscience, Год журнала: 2024, Номер unknown

Опубликована: Фев. 27, 2024

The growing interest in the rapid and sustained antidepressant effects of dissociative anesthetic ketamine classic psychedelics, such as psilocybin, is remarkable. However, both psychedelics are known to induce acute mystical experiences; can cause symptoms out-of-body experience, while typically bring about hallucinogenic experiences, like a profound sense unity with universe or nature. role these experiences enhancing outcomes for patients depression currently an area ongoing investigation debate. Clinical studies have shown that following administration (S)-ketamine (esketamine) not directly linked their properties. In contrast, potential (R)-ketamine (arketamine), thought lack side effects, has yet be conclusively proven large-scale clinical trials. Moreover, although activation serotonin 5-HT

Язык: Английский

Процитировано

30

Novel Pyridine Derivatives as 5-HT2A Agonists for Treating Psychiatric Disorders DOI Creative Commons
Ram W. Sabnis, Anika R. Sabnis

ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер 16(2), С. 192 - 193

Опубликована: Янв. 8, 2025

Provided herein are novel pyridine derivatives as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychiatric disorders, and processes for preparing compounds.

Язык: Английский

Процитировано

3

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits DOI Creative Commons
Elk Kossatz, Rebeca Dı́ez-Alarcia,

Supriya A. Gaitonde

и другие.

Nature Communications, Год журнала: 2024, Номер 15(1)

Опубликована: Май 29, 2024

Abstract G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular pathways upon activation. Complete (in)activation of all can be counterproductive for specific therapeutic applications. This is the case serotonin 2 A receptor (5-HT 2A R), a prominent target treatment schizophrenia. In this study, we elucidate complex 5-HT R coupling signature in response different probes, and its physiological consequences by combining computational modeling, vitro vivo experiments with human postmortem brain studies. We show how chemical modification endogenous agonist dramatically impacts protein profile associated behavioral responses. Importantly, among these responses, demonstrate that memory deficits regulated αq activation, whereas psychosis-related behavior modulated through αi1 stimulation. These findings emphasize complexity GPCR pharmacology physiology open path designing improved therapeutics stchizophrenia.

Язык: Английский

Процитировано

10

Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats DOI Creative Commons
Zitong Wang, Brett Robbins, R. L. Zhuang

и другие.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2025, Номер unknown, С. 111243 - 111243

Опубликована: Янв. 1, 2025

Chronic stress exerts profound effects on mental health, contributing to disorders such as depression, anxiety, and cognitive impairment. This study examines the potential of psilocybin alleviate behavioral despair deficits in a rodent model chronic stress, focusing interplay between Hypothalamic-Pituitary-Adrenal (HPA) axis Endocannabinoid System (ECS). Twenty-two male Wistar rats were divided into control groups. Animals within group exposed predator odor social instability induce either sham treated, or given psilocybin. Behavioral assessments conducted using Open Field Test, Sucrose Preference Novel Object Recognition, Elevated Plus Maze, Forced Swimming Test evaluate locomotion, anhedonia, memory, despair, respectively. Blood brain samples analyzed for biochemical markers. Results indicated that significantly reduced stress-induced impairments, likely through ECS-mediated downregulation HPA axis. These findings suggest early intervention with has sustained beneficial stress-related disturbances, underscoring its novel therapeutic approach health disorders.

Язык: Английский

Процитировано

1

Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqα DOI Creative Commons
Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia

и другие.

FEBS Letters, Год журнала: 2025, Номер unknown

Опубликована: Янв. 26, 2025

5HT 2A R is a G‐protein‐coupled receptor that drives many neuronal functions and target for psychedelic drugs. Understanding ligand interactions conformational transitions essential developing effective pharmaceuticals, but mechanistic details of activation remain poorly understood. We utilized all‐atom molecular dynamics simulations free‐energy calculations to investigate R's upon binding serotonin psilocin. show the active state collapses closed in absence Gqα, underscoring importance G‐protein coupling. discover an intermediate “partially‐open” conformation. Both ligands have higher affinities orthosteric than extended pocket. These findings enhance our understanding may aid novel therapeutics. Impact statement This study sheds light on activation, revealing conformations dynamics. insights could drug development neurological psychiatric disorders, benefiting researchers clinicians pharmacology neuroscience.

Язык: Английский

Процитировано

1

Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder DOI Creative Commons
Ram W. Sabnis

ACS Medicinal Chemistry Letters, Год журнала: 2024, Номер 16(1), С. 18 - 19

Опубликована: Дек. 10, 2024

Provided herein are novel 3-pyrrolidineindole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis and mental illnesses depression post-traumatic stress disorder, processes for preparing compounds.

Язык: Английский

Процитировано

7

Psychoactive substances for the treatment of neuropsychiatric disorders DOI

Zifan Zhen,

Xueqiang Sun,

Shiying Yuan

и другие.

Asian Journal of Psychiatry, Год журнала: 2024, Номер 101, С. 104193 - 104193

Опубликована: Сен. 3, 2024

Язык: Английский

Процитировано

4

N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data DOI

Steven A. Barker

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2025, Номер unknown, С. 111259 - 111259

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists DOI Creative Commons
Trevor Sharp, Aurelija Ippolito

British Journal of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Май 23, 2025

Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because their association with counterculture movements a perceived concern about harm through recreational use, consequent legal prohibition in early 1970s. However, these are now experiencing renaissance field psychiatry based on increasing evidence that they can produce long‐lasting improvements health across wide variety mental illnesses, including major depression, addictions anxiety disorders. These interact many different 5‐HT receptor subtypes but powerful psychedelic experience, which (depending set setting) includes profound alterations perception, mood cognition, accompanied by vivid hallucinations, is widely considered mediated an agonist action at 2A receptors. link between agonism therapeutic effects currently uncertain. Indeed, recent has revealed new class agonists appear retain potential psychedelics without inducing disorienting hallucinatory experiences. Biased signalling, partial non‐selectivity amongst possible explanations for differential properties drugs, whereas increased neuroplasticity offers likely account common effects. This article explores neuropsychopharmacological hallucinogenic non‐hallucinogenic context promise novel drug treatments psychiatry.

Язык: Английский

Процитировано

0

Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists DOI Creative Commons
Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits

и другие.

Journal of Medicinal Chemistry, Год журнала: 2024, Номер 67(9), С. 7224 - 7244

Опубликована: Апрель 22, 2024

Classical psychedelics such as psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltryptamine (DMT) are showing promising results in clinical trials for a range of psychiatric indications, including depression, anxiety, substance abuse disorder. These compounds characterized by broad pharmacological activity profiles, while the acute mind-altering effects can be ascribed to their shared agonist at serotonin 2A receptor (5-HT2AR), apparent persistent therapeutic yet decidedly linked this receptor. We report herein discovery 2,5-dimethoxyphenylpiperidines novel class selective 5-HT2AR agonists detail structure–activity investigations leading identification LPH-5 [analogue (S)-11] with desirable drug-like properties.

Язык: Английский

Процитировано

3